MiroBio
Latest round
- Series B
Last raised
- Jun 2022
Total raised
- $130M
Investors
- 7
About MiroBio
MiroBio Ltd is a biotechnology company focused on developing innovative therapies aimed at modulating the immune system.MiroBio Ltd, founded in 2019 in Oxford, UK, specializes in immunotherapeutic products. The company has not indicated any major pivots in its strategy or operations. MiroBio was acquired by Gilead Sciences, Inc.00 mn, marking a significant milestone in its growth trajectory.The company specializes in a range of innovative products designed to modulate immune responses, specifically focusing on immune inhibitory receptor agonists.The revenue model of MiroBio Ltd is structured around B2B partnerships with clients engaging through direct sales. Their flagship offerings are available as one-time purchases, ensuring a steady stream of income., MiroBio Ltd aims to leverage Gilead’s resources to enhance its proprietary discovery platform and expand its portfolio of immune inhibitory receptor agonists. Plans for future growth include the development of new therapeutics targeting specific immune pathways, with expectations for product launches in the coming years.
Who invested in MiroBio
7 investors across 2 rounds
See all investors in MiroBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about MiroBio
Who invested in MiroBio?
MiroBio has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MiroBio raised?
MiroBio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did MiroBio last raise money?
MiroBio's most recent round on record is a Series B, in Jun 2022.
What does MiroBio do?
MiroBio Ltd is a biotechnology company focused on developing innovative therapies aimed at modulating the immune system.
Where is MiroBio headquartered?
MiroBio is headquartered in Oxford, UK.
Which VCs invest in companies like MiroBio?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at MiroBio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like MiroBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.